跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,392 条关于
“HTT mRNA”
全部
5,392
临床试验
2,618
药物
1,163
机构
28
资讯
1,583
2年前
Skyhawk's SKY-0515 Shows Promise in Huntington's Disease with 72% HTT mRNA Reduction
8个月前
Oral HTT-Lowering Drug Branaplam Shows Promise but Halted Due to Peripheral Neuropathy in Phase 2 Huntington's Disease Trial
3个月前
Huntington's Disease Market Poised for 14% CAGR Growth Through 2036 as Disease-Modifying Therapies Advance
去年
Skyhawk Therapeutics Initiates Phase 2/3 Trial of SKY-0515 for Huntington's Disease
4个月前
PTC Therapeutics Reports Positive 24-Month Data for Votoplam in Huntington's Disease Extension Study
去年
Merck KGaA Partners with Skyhawk Therapeutics in $2 Billion RNA Splicing Collaboration for Neurological Disorders
去年
Huntington's Disease: Disease-Modifying Therapies on the Horizon After Decades of Setbacks
去年
PTC518 Shows Promise in Huntington's Disease: Phase 2 Trial Meets Primary Endpoint
去年
Huntington's Disease Pipeline Shows Robust Growth with 20+ Companies Developing Novel Therapies
去年
Alnylam's ALN-HTT02: First Patient Dosed in Phase 1 Huntington's Disease Trial
第 1 页,共 159 页
上一页
下一页